Owen N. Witte - Net Worth and Insider Trading
Owen N. Witte Net Worth
The estimated net worth of Owen N. Witte is at least $14 Million dollars as of 2024-11-13. Owen N. Witte is the Director of Kite Pharma Inc and owns about 76,250 shares of Kite Pharma Inc (KITE) stock worth over $14 Million. Owen N. Witte is also the Director of Allogene Therapeutics Inc and owns about 218,271 shares of Allogene Therapeutics Inc (ALLO) stock worth over $619,890. Details can be seen in Owen N. Witte's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Owen N. Witte has not made any transactions after 2022-08-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Owen N. Witte
Owen N. Witte Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Owen N. Witte owns 2 companies in total, including Allogene Therapeutics Inc (ALLO) , and Kite Pharma Inc (KITE) .
Click here to see the complete history of Owen N. Witte’s form 4 insider trades.
Insider Ownership Summary of Owen N. Witte
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-08-12 | director |
| KITE | Kite Pharma Inc | 2017-10-03 | director |
Owen N. Witte Latest Holdings Summary
Owen N. Witte currently owns a total of 2 stocks. Among these stocks, Owen N. Witte owns 76,250 shares of Kite Pharma Inc (KITE) as of June 26, 2017, with a value of $14 Million and a weighting of 95.67%. Owen N. Witte also owns 218,271 shares of Allogene Therapeutics Inc (ALLO) as of August 12, 2022, with a value of $619,890 and a weighting of 4.33%.
Latest Holdings of Owen N. Witte
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KITE | Kite Pharma Inc | 2017-06-26 | 76,250 | 179.79 | 13,708,988 |
| ALLO | Allogene Therapeutics Inc | 2022-08-12 | 218,271 | 2.84 | 619,890 |
Holding Weightings of Owen N. Witte
Owen N. Witte Form 4 Trading Tracker
According to the SEC Form 4 filings, Owen N. Witte has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 25,000 shares on June 26, 2017, which brought Owen N. Witte around $3 Million.
According to the SEC Form 4 filings, Owen N. Witte has made a total of 6 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 15,000 shares on August 12, 2022, which brought Owen N. Witte around $251,250.
Insider Trading History of Owen N. Witte
- 1
Owen N. Witte Trading Performance
GuruFocus tracks the stock performance after each of Owen N. Witte's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Owen N. Witte is 3.67%. GuruFocus also compares Owen N. Witte's trading performance to market benchmark return within the same time period. The performance of stocks bought by Owen N. Witte within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Owen N. Witte's insider trading performs compared to the benchmark.
Performance of Owen N. Witte
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.11 | | | | | |
| Relative Return to S&P 500(%) | 0.64 | | | | | |
Owen N. Witte Ownership Network
Ownership Network List of Owen N. Witte
Ownership Network Relation of Owen N. Witte
Owen N. Witte Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
Owen N. Witte is the director of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, Owen N. Witte made no insider transaction in Allogene Therapeutics Inc (ALLO). Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 37,281 shares made by Deborah M. Messemer , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 11,200 shares made by Franz B Humer .
In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,481 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,665,846 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
Owen N. Witte Mailing Address
Above is the net worth, insider trading, and ownership report for Owen N. Witte. You might contact Owen N. Witte via mailing address: C/o Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
